NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Varex Imaging Corporation (VREX) Stock Analysis

Varex Imaging Corporation (VREX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

VREX

$18.42

+$0.02 (+0.11%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare VREX with… →

VREX Key Statistics

As of Oct 21, 2026
Trading
Open
$18.43
Previous Close
$18.40
Day's Range
18.42–18.45
52-Week Range
9.09–18.63
Volume
459.32K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.97
Valuation
Market Cap
$782.18M
P/E Ratio
34.75
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.21
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
4.98
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.90
EPS (ttm)Profit attributable to each share over the last twelve months.
0.53
Financials (FY)
Revenue (FY)
$844.60M+4.14%
Net Income (FY)
−$70.30M
Profit marginThe share of revenue left as profit after all costs and taxes.
2.56%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
42.46M
1-Year Return
+58.11%
Dividend and dates
Earnings Date
November 17, 2026estimated
Avg Volume
851.82K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, VREX closed at $18.42, +58.11% over 1 year.

Varex Imaging Corporation (VREX) has a market capitalization of $782.18M.

In fiscal 2025, VREX reported revenue of $844.60M.

VREX Stock Return by Calendar Year

Varex Imaging Corporation (VREX) return since Jan 2017: what $10,000 became

1 year
$10,000 $15,811
+58.11%
5 years
$10,000 $6,850
−31.50%
Since Jan 2017
$10,000 $6,822
−31.78%

If you had invested $10,000 in Varex Imaging Corporation (VREX) at the close on January 23, 2017, the earliest close on record here, it would have been worth $6,822 at the close on October 21, 2026: −31.78% in total, −3.85% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+58.11%
2025−20.15%
2024−28.83%
2023+0.99%
2022−35.66%
2021+89.15%
2020−44.05%
2019+25.89%
2018−41.05%
2017+48.78%

As of October 21, 2026.

VREX Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$844.60M−$70.30M−8.3%
2024$811.00M−$48.80M−6.0%
2023$893.40M$47.40M5.3%
2022$859.40M$30.30M3.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$844.60M$290.50M$66.10M−$70.30M−8.3%
2024$811.00M$256.90M$32.10M−$48.80M−6.0%
2023$893.40M$290.30M$77.10M$47.40M5.3%
2022$859.40M$283.50M$88.20M$30.30M3.5%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

VREX Valuation vs Medical Devices Median

Median of 145 stocks
MetricVREXMedical Devices medianvs median
P/E34.7527.0828% above
P/S ratio0.902.5364% below
Profit margin2.56%−14.78%17.3 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 9 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Varex Imaging Corporation (VREX) is capitalised at $782.18M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 2,500 employees.

The 52-week range on file runs from $9.09 to $18.63. The most recent close on file for VREX is $18.42, dated October 21, 2026. That is +$0.02 (+0.11%) against the previous close. The latest close sits 102.64% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $844.60M. Against the prior fiscal year total of $811.00M, that is a change of +4.14%. The same year closed with a net loss of $70.30M. The reported profit margin is 2.56%. That is 17.3 percentage points above the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to 0.53.

Across the 4 fiscal years on file, revenue moves from $859.40M in 2022 to $844.60M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 34.75. That is 28.32% above the Medical Devices median of 27.08. On forward earnings the ratio is 17.21. The PEG ratio, which sets the P/E against expected earnings growth, reads 4.98. Measured against sales, the shares trade at 0.9 times revenue. On price-to-sales that is 64.25% below the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is +58.11%. Across 5 years the annualized return works out at −7.29%. Beta against the wider market is reported at 0.97. Annualized volatility over the trailing 9 years is 48.85%.

Growth & Income

The record shows no dividend for VREX.

So far in 2026 the total return is +58.11%. Across the complete calendar years on file, 2021 returned +89.15% and 2020 returned −44.05%. Of the 9 complete calendar years on file, 4 finished higher.

Peer Comparison

Varex Imaging Corporation (VREX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Varex Imaging Corporation VREX $782.18M 34.8
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Varex Imaging Corporation trades at a P/E of 34.8.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Varex Imaging Corporation

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Visit website →